Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q2 2026
Institutional positions in Sunshine Biopharma Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −3 vs. Q1 2026
- Shares held
- 15.5K
- −106.7K (−87.3%) vs. Q1 2026
- Total value
- $32.6K
- −$94.5K (−74.3%) vs. Q1 2026
- New holders
- 3
- 0 more added
- Sold out
- 6
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 16 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 14,974 | $31.4K | 0.00% | +14,974 | New |
| Morgan Stanley | 385 | $808 | 0.00% | −14,249−97.4% | Reduced |
| SBI Securities Co., Ltd. | 162 | $340 | 0.00% | −1,672−91.2% | Reduced |
| National Bank of Canada | 5 | $10 | 0.00% | −4−44.4% | Reduced |
| Advisor Group Holdings, Inc. | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $2 | 0.00% | +1 | New |
| Strive Financial Group ,LLC | 1 | $2 | 0.00% | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −46,248−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −23,482−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,457−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −13,437−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,103−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |